Morphological and quantitative analysis of vascular wall and neointimal hyperplasia after coronary stenting: comparison of bare-metal and sirolimus-eluting stents using optical coherence tomography

Circ J. 2011;75(7):1633-40. doi: 10.1253/circj.cj-10-1237. Epub 2011 May 28.

Abstract

Background: It has been suggested that sirolimus-eluting stents (SES) provoke a more sustained inflammatory response (IR) in neointimal hyperplasia (NIH). The purpose of this study was to compare morphological vessel characteristics, including post-stent IR in NIH, between patients with SES and bare metal stents (BMS) using optical coherence tomography (OCT).

Methods and results: Thirty-seven patients underwent OCT at their post-stent follow-up. OCT signal-intensity deviation (normalized standard-deviation; OCT-NSD) values in NIH were compared between the 2 groups. In addition, the serum concentration of high-sensitivity C-reactive protein (hs-CRP) was measured. Stent-malapposition rate (1.78% vs. 0.7%; P = 0.016), uncovered stent-strut rate (16% vs. 3.7%; P = 0.0002), peri-stent ulcer like appearance (PSUA; 50% vs. 0%; P = 0.006) were all significantly higher in the SES group than in the BMS group, respectively. The OCT-NSD value was also significantly higher in the SES group than in the BMS group (0.213 ± 0.005 vs. 0.198 ± 0.005; P < 0.001), as was the hs-CRP level (2.54 ± 1.89 vs. 0.64 ± 0.3 mg/L; P = 0.0006). In addition, a significant positive correlation was found between hs-CRP and OCT-NSD (r = 0.471; P = 0.0025).

Conclusions: PSUA-morphology was specific in the SES group, and higher levels of OCT-NSD and hs-CRP after SES implantation suggest sustained IR in NIH compared with following BMS implantation. These different characteristics may be some of the background that promotes thrombus formation as a late-stage post-stent complication of SES.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Angioplasty, Balloon, Coronary
  • Biomarkers / blood
  • C-Reactive Protein / metabolism
  • Coronary Angiography
  • Coronary Artery Disease / pathology
  • Coronary Artery Disease / therapy
  • Coronary Vessels / diagnostic imaging
  • Coronary Vessels / pathology*
  • Drug-Eluting Stents / adverse effects*
  • Female
  • Humans
  • Hyperplasia / blood
  • Hyperplasia / etiology
  • Hyperplasia / pathology
  • Inflammation / blood
  • Inflammation / etiology
  • Inflammation / pathology
  • Male
  • Metals*
  • Middle Aged
  • Neointima / diagnostic imaging
  • Neointima / pathology*
  • Sirolimus*
  • Stents / adverse effects*
  • Tomography, Optical Coherence*
  • Ultrasonography, Interventional

Substances

  • Biomarkers
  • Metals
  • C-Reactive Protein
  • Sirolimus